Status: current, Defined. Date: 31-May 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4127961000168117 | Nesina Met 12.5 mg/500 mg (alogliptin 12.5 mg + metformin hydrochloride 500 mg) tablet, 180 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4127971000168111 | Nesina Met 12.5 mg/500 mg tablet, 180 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Nesina Met 12.5 mg/500 mg tablet, 180 | Is a | alogliptin 12.5 mg + metformin hydrochloride 500 mg tablet, 180 | true | Inferred relationship | Some | ||
| Nesina Met 12.5 mg/500 mg tablet, 180 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Nesina Met 12.5 mg/500 mg tablet, 180 | has TPUU | Nesina Met 12.5 mg/500 mg tablet | true | Inferred relationship | Some | 1 | |
| Nesina Met 12.5 mg/500 mg tablet, 180 | has TP | Nesina Met 12.5 mg/500 mg | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nesina Met 12.5 mg/500 mg tablet, 180, blister pack | Is a | True | Nesina Met 12.5 mg/500 mg tablet, 180 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR